You may download, free of charge, the PDF version of your paper or the full volume of HA&RCP from our website after free registration. You can also access all articles published in HA&RCP. - http://www.heroinaddictionrelatedclinicalproblems.org If there is any request for this paper, readers should download it directly from the HARCP website given here.
You may download, free of charge, the PDF version of your paper or the full volume of HA&RCP from our website after free registration. You can also access all articles published in HA&RCP.
- http://www.heroinaddictionrelatedclinicalproblems.org
If there is any request for this paper, readers should download it directly from the HARCP website given here.
All documents in ORBi are protected by a user license.
[en] Background: Heroin-assisted treatment (HAT) can improve the condition of heroin addicts who are resistant to other treatments. However, in a new HAT trial in Belgium, fewer subjects than expected were included. Aim: Our research team explored the reasons given by heroin users in explaining why they did not want to participate. Methods: In 2011, during the trial recruitment, we interviewed heroin users (n=52) who never took the opportunity to meet the research team during the recruitment process preceding the trial. Results: Of those 52 heroin users, 25 were afraid of the limited length of the HAT and 11 feared becoming more dependent as a result of HAT. Conclusion: A trial that was planned to last for a limited length of time may have demotivated heroin users who could otherwise have benefited from this new programme.
Disciplines :
Public health, health care sciences & services
Author, co-author :
Demaret, Isabelle ; Université de Liège - ULiège > Département des sciences cliniques > Psychiatrie et psychologie médicale
Litran, Géraldine; Université de Liège - ULiège > Service de Psychiatrie et Institut des Sciences Humaines et Sociales (Criminologie)
Magoga, Cécile; Université de Liège - ULiège > Service de Psychiatrie et Institut des Sciences Humaines et Sociales (Criminologie)
Deblire, Clémence; Université de Liège - ULiège > Service de Psychiatrie et Institut des Sciences Humaines et Sociales (Criminologie)
Dupont, Anicée; Université de Liège - ULiège > Ecole de Santé publique
De Roubaix, Jérôme; Université de Liège - ULiège > Service de Psychiatrie et Institut des Sciences Humaines et Sociales (Criminologie)
Lemaître, André ; Université de Liège - ULiège > Institut des sciences humaines et sociales > Criminologie
ANSSEAU, Marc ; Centre Hospitalier Universitaire de Liège - CHU > Psychiatrie et psychologie médicale
Language :
English
Title :
Why do heroin users refuse to participate in a heroin-assisted treatment trial?
Alternative titles :
[fr] Pourquoi des consommateurs d'héroïne refusent-ils de rentrer dans une étude sur le traitement assisté par héroïne ?
Publication date :
22 March 2014
Journal title :
Heroin Addiction and Related Clinical Problems
ISSN :
1592-1638
Publisher :
PACINI EDITORE, Pisa, Italy
Volume :
Epub ahead of print, March 22, 2014
Peer reviewed :
Peer reviewed
Name of the research project :
TADAM, un projet pilote de traitement par diacétylmorphine
Funders :
SPF Santé - Service Public Fédéral Santé publique. Sécurité de la Chaîne alimentaire et Environnement Liège - Ville de Liège ULiège - Université de Liège
Commentary :
Peut être téléchargé via le site de la revue : http://www.heroinaddictionrelatedclinicalproblems.org
Amato L., Davoli M., Perucci C. A., Ferri M., Faggiano F., Mattick R. P. (2005): An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J Subst Abuse Treat. 28(4): 321-329.
Central Committee on the Treatment of Heroin Addicts (2002). Medical co-prescription of heroin: Two randomized controlled trials: Utrecht, the Netherlands. p 180.
Demaret I., Herne P., Lemaitre A., Ansseau M. (2011): Feasibility assessment of heroin-assisted treatment in Liege, Belgium. Acta Psychiatrica Belgica. 111(1): 3-8.
Demaret I., Lemaitre A., Ansseau M. (2012): Staff concerns in heroin-assisted treatment centres. J Psychiatr Ment Health Nurs. 19(6): 563-567.
Ferri M., Davoli M., Perucci C. A. (2011): Heroin maintenance for chronic heroin-dependent individuals. Cochrane Database Syst Rev(12): CD003410.
Gartry C. C., Oviedo-Joekes E., Laliberte N., Schechter M. T. (2009): NAOMI: The trials and tribulations of implementing a heroin assisted treatment study in North America. Harm Reduct J. 6: 2.
Haasen C., Verthein U., Degkwitz P., Berger J., Krausz M., Naber D. (2007): Heroin-assisted treatment for opioid dependence: randomised controlled trial. Br J Psychiatry. 191: 55-62.
Leshner A. I. (1997): Addiction is a brain disease, and it matters. Science. 278(5335): 45-47.
Lintzeris N., Strang J., Metrebian N., Byford S., Hallam C., Lee S., Zador D. (2006): Methodology for the Randomised Injecting Opioid Treatment Trial (RIOTT): evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UK. Harm Reduct J. 3: 28.
March J. C., Oviedo-Joekes E., Perea-Milla E., Carrasco F. (2006): Controlled trial of prescribed heroin in the treatment of opioid addiction. J Subst Abuse Treat. 31(2): 203-211.
Maremmani A. G. I., Rovai L., Rugani F., Pacini M., Lamanna F., Bacciardi S., Perugi G., Deltito J., Dell'osso L., Maremmani I. (2012): Correlations between awareness of illness (insight) and history of addiction in heroin-addicted patients. Front Psychiatry. 3.
Mattick R. P., Kimber J., Breen C., Davoli M. (2008): Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev (2): CD002207.
Miller C. L., Strathdee S. A., Kerr T., Small W., Li K., Wood E. (2005): Factors associated with willingness to participate in a heroin prescription program among injection drug users. J Opioid Manag. 1(4): 201-203.
Naber D., Haasen C. (2006). The German model project for heroin assisted treatment of opioid dependend patients: A multi-centre, randomised, controlled treatment study.: Hambourg, Germany. p 167.
Oviedo-Joekes E., Brissette S., Marsh D. C., Lauzon P., Guh D., Anis A., Schechter M. T. (2009): Diacetylmorphine versus methadone for the treatment of opioid addiction. N Engl J Med. 361(8): 777-786.
Oviedo-Joekes E., Nosyk B., Brissette S., Chettiar J., Schneeberger P., Marsh D. C., Krausz M., Anis A., Schechter M. T. (2008): The North American Opiate Medication Initiative (NAOMI): profile of participants in North America's first trial of heroin-assisted treatment. J Urban Health. 85(6): 812-825.
Perneger T. V., Giner F., Del Rio M., Mino A. (1998): Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. BMJ. 317(7150): 13-18.
Strang J., Metrebian N., Lintzeris N., Potts L., Carnwath T., Mayet S., Williams H., Zador D., Evers R., Groshkova T., Charles V., Martin A., Forzisi L. (2010): Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial. Lancet. 375(9729): 1885-1895.
Van Den Brink W., Hendriks V. M., Blanken P., Koeter M. W., Van Zwieten B. J., Van Ree J. M. (2003): Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials. BMJ. 327(7410): 310.
